How we can help you

Targeted collection design

Design a tailored collection of synthesizable molecules for your target (from hundreds to thousands of molecules) ranked by affinity, selectivity, ADMET ready to synthetize and incorporate to your screening collection.

Virtual library expansion from confirmed hits

Hit Identification Follow-Up. Generate virtual libraries of novel molecules inspired by your hits based on vast chemical collections. Explore diverse chemical modifications while optimizing potency, selectivity and drug-like properties, customizable to your expectations.

Iterative DMTA optimization with experimental integration

Hit-to-Lead Optimization with Experimental Feedback. Incorporate your experimental results into the predictions based on KAMPAÏ Explainable AI and Active Learning in a Design-Make-Test-Analyse (DMTA) design process, while ensuring proposed molecules are synthesizable and available from commercial suppliers.

How we work

01

Legal Agreement

Define collaboration terms and risk-sharing levels, with Go/No-Go decisions at key milestones.

02

Data Sharing

You provide target information, screening data, hit structures, and potency results.

03

Target Profile Definition

Together we agree on the desired molecule profile (potency, selectivity, ADMET).

04

AI-Driven Optimization

In silico AI design, analysis, and delivery of molecules in a DMTA process.

05

Experimental Validation

You test the proposed molecules, feeding results back into KAMPAÏ for continuous optimization.

 

Ready to start your hit identification or optimization campaign?

Share your target, screening data, and hit structures; and we will define the molecule profile and design the first iteration together.